Afrocentric Investment (JSE:ACT) Buyback Yield % : 0.00 (As of Jun. 08, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Afrocentric Investment's current buyback yield was 0.00%.

Afrocentric Investment Buyback Yield % Historical Data

The historical data trend for Afrocentric Investment's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment Buyback Yield % Chart

Afrocentric Investment Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Buyback Yield %

Get a 7-Day Free Trial

Afrocentric Investment Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Afrocentric Investment's Buyback Yield %

For the Medical Care Facilities subindustry, Afrocentric Investment's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Afrocentric Investment's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's Buyback Yield % falls into.

Afrocentric Investment Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Afrocentric Investment's Buyback Yield for the fiscal year that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	3383.5697
	=	0.00%

Afrocentric Investment's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	2	/	2700.5814
	=	0.00%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2023) data.

Afrocentric Investment Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Afrocentric Investment (JSE:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Conrad Road, Florida North, Roodepoort, ZAF, 1709

Website

http://www.afrocentric.za.com

Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.